Consistent with our result, a previous study showed that β-catenin and TCF4, a member of T-cell and lymphoid enhancer (TCF/LEF) factor family, could bind to and regulate MIR17HG promoter in colorectal cancer (Li et al., 2016). This evidence concerns the gene MIR17HG and colorectal cancer.